Literature DB >> 14688181

Prevalence of circulating procoagulant microparticles in women with recurrent miscarriage: a case-controlled study.

Howard Carp1, Rima Dardik, Aharon Lubetsky, Ophira Salomon, Regina Eskaraev, Esther Rosenthal, Aida Inbal.   

Abstract

BACKGROUND: Circulating microparticles are markers of cell activation associated with various prothrombotic states. As hypoxia due to uteroplacental thrombosis is considered to be one of the causes of pregnancy loss, microparticles may be associated with pregnancy loss, in addition to, or as part of, other procoagulant states such as antiphospholipid syndrome or hereditary thrombophilias. The objective of this study was to examine the prevalence of circulating microparticles in women with recurrent pregnancy loss.
METHODS: A total of 96 women with recurrent pregnancy losses were enrolled in a case-control study and compared with 90 parous women. Microparticles were measured by flow cytometry using fluorescent anti-CD51/CD31 antibodies.
RESULTS: Microparticle levels >2 SD above the mean of controls (57,700/ml) were detected in 12 out of 96 women with recurrent miscarriages (12.5%), compared with two of the 90 control women (2.2%), P<0.008. The titre of microparticles did not correlate with age, number of pregnancy losses, primary secondary or tertiary aborters status, or with pregnancy losses in the 1st or 2nd trimesters.
CONCLUSIONS: A proportion of women with pregnancy loss have elevated endothelial microparticles suggesting that endothelial damage or activation might be associated with the pathogenesis of pregnancy loss.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14688181     DOI: 10.1093/humrep/deg512

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  11 in total

1.  Profibrinolytic microparticles are not adequately produced to compensate their prothrombotic effect.

Authors:  Rucha Patil; Kanjaksha Ghosh; Shrimati Shetty
Journal:  Haematologica       Date:  2013-07       Impact factor: 9.941

2.  Biological properties of extracellular vesicles and their physiological functions.

Authors:  María Yáñez-Mó; Pia R-M Siljander; Zoraida Andreu; Apolonija Bedina Zavec; Francesc E Borràs; Edit I Buzas; Krisztina Buzas; Enriqueta Casal; Francesco Cappello; Joana Carvalho; Eva Colás; Anabela Cordeiro-da Silva; Stefano Fais; Juan M Falcon-Perez; Irene M Ghobrial; Bernd Giebel; Mario Gimona; Michael Graner; Ihsan Gursel; Mayda Gursel; Niels H H Heegaard; An Hendrix; Peter Kierulf; Katsutoshi Kokubun; Maja Kosanovic; Veronika Kralj-Iglic; Eva-Maria Krämer-Albers; Saara Laitinen; Cecilia Lässer; Thomas Lener; Erzsébet Ligeti; Aija Linē; Georg Lipps; Alicia Llorente; Jan Lötvall; Mateja Manček-Keber; Antonio Marcilla; Maria Mittelbrunn; Irina Nazarenko; Esther N M Nolte-'t Hoen; Tuula A Nyman; Lorraine O'Driscoll; Mireia Olivan; Carla Oliveira; Éva Pállinger; Hernando A Del Portillo; Jaume Reventós; Marina Rigau; Eva Rohde; Marei Sammar; Francisco Sánchez-Madrid; N Santarém; Katharina Schallmoser; Marie Stampe Ostenfeld; Willem Stoorvogel; Roman Stukelj; Susanne G Van der Grein; M Helena Vasconcelos; Marca H M Wauben; Olivier De Wever
Journal:  J Extracell Vesicles       Date:  2015-05-14

Review 3.  Extracellular vesicles and their immunomodulatory functions in pregnancy.

Authors:  Soumyalekshmi Nair; Carlos Salomon
Journal:  Semin Immunopathol       Date:  2018-04-03       Impact factor: 9.623

Review 4.  Extracellular vesicles and immune response during pregnancy: A balancing act.

Authors:  Adrian E Morelli; Yoel Sadovsky
Journal:  Immunol Rev       Date:  2022-02-23       Impact factor: 10.983

5.  Circulating levels of matrix proteases and their inhibitors in pregnant women with and without a history of recurrent pregnancy loss.

Authors:  Dilly O C Anumba; Saad El Gelany; Sarah L Elliott; Tin C Li
Journal:  Reprod Biol Endocrinol       Date:  2010-06-16       Impact factor: 5.211

Review 6.  The promise of placental extracellular vesicles: models and challenges for diagnosing placental dysfunction in utero†.

Authors:  Lindsey N Block; Brittany D Bowman; Jenna Kropp Schmidt; Logan T Keding; Aleksandar K Stanic; Thaddeus G Golos
Journal:  Biol Reprod       Date:  2021-01-04       Impact factor: 4.161

7.  The role of d-dimer as first marker of thrombophilia in women affected by sterility: implications in pathophysiology and diagnosis of thrombophilia induced sterility.

Authors:  Pierpaolo Di Micco; Maristella D'Uva; Ida Strina; Antonio Mollo; Valeria Amato; Alferio Niglio; Giuseppe De Placido
Journal:  J Transl Med       Date:  2004-11-09       Impact factor: 5.531

Review 8.  Multiomic immune clockworks of pregnancy.

Authors:  Laura S Peterson; Ina A Stelzer; Amy S Tsai; Mohammad S Ghaemi; Xiaoyuan Han; Kazuo Ando; Virginia D Winn; Nadine R Martinez; Kevin Contrepois; Mira N Moufarrej; Stephen Quake; David A Relman; Michael P Snyder; Gary M Shaw; David K Stevenson; Ronald J Wong; Petra Arck; Martin S Angst; Nima Aghaeepour; Brice Gaudilliere
Journal:  Semin Immunopathol       Date:  2020-02-04       Impact factor: 9.623

9.  Clinical CVVH model removes endothelium-derived microparticles from circulation.

Authors:  Abdelhafeez H Abdelhafeez; Paul M Jeziorczak; Terry R Schaid; Susan L Hoefs; Sushma Kaul; Rahul Nanchal; Elizabeth R Jacobs; John C Densmore
Journal:  J Extracell Vesicles       Date:  2014-02-27

10.  Elevated procoagulant endothelial and tissue factor expressing microparticles in women with recurrent pregnancy loss.

Authors:  Rucha Patil; Kanjaksha Ghosh; Purnima Satoskar; Shrimati Shetty
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.